Comments
Zydus Cadila has launched generic Vardenafil Hydrochloride tablets used for the treatment of erectile dysfunction in the American market.
According to a company statement, Zydus has launched the tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg in the US market after receiving final approval from the United States Food and Drug Adminstration. The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.
The group has also received final approval from the USFDA to market generic Ursodiol tablets, 250 mg and 500 mg, which will be manufactured at the group’s formulations manufacturing facility at Baddi. Ursodiol tablets are indicated for the treatment of patients with primary biliary cirrhosis, a chronic disease in which the bile ducts in liver are slowly destroyed.
The group now has 226 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since the commencement of its filing process.
Shares of Cadila Healthcare, the listed entity of the group, were trading at Rs 358.85 on the BSE, up 0.01 per cent from their previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.